UBS Group AG - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 70 filers reported holding APREA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$8,494
+112.4%
25,739
+333.2%
0.00%
Q3 2022$4,000
-50.0%
5,942
-42.5%
0.00%
Q2 2022$8,000
-20.0%
10,332
+96.4%
0.00%
Q1 2022$10,0005,260
+6913.3%
0.00%
Q4 2021$0
-100.0%
75
-94.3%
0.00%
Q2 2021$6,000
-53.8%
1,322
-46.8%
0.00%
Q1 2021$13,000
+333.3%
2,485
+251.0%
0.00%
Q4 2020$3,000
+200.0%
708
+1670.0%
0.00%
Q3 2020$1,000
-99.2%
40
-98.7%
0.00%
Q2 2020$123,000
-19.1%
3,178
-27.4%
0.00%
Q1 2020$152,000
-46.3%
4,377
-29.0%
0.00%
Q4 2019$283,0006,1610.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders